Profile data is unavailable for this security.
About the company
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.
- Revenue in CAD (TTM)3.04m
- Net income in CAD-19.13m
- Incorporated2003
- Employees55.00
- LocationSQI Diagnostics Inc36 Meteor DrETOBICOKE M9W 1A4CanadaCAN
- Phone+1 (416) 674-9500
- Fax+1 (416) 674-9500
- Websitehttps://sqidiagnostics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CardioComm Solutions Inc | 643.05k | -141.08k | 1.93m | 16.00 | -- | -- | -- | 3.00 | -0.0009 | -0.0009 | 0.0043 | -0.0035 | 1.62 | 1.28 | 3.63 | -- | -35.58 | -56.56 | -- | -- | 92.09 | 79.38 | -21.94 | -28.73 | 0.2911 | -9.29 | -- | -- | -11.99 | -4.01 | -3,856.50 | -- | -34.07 | -- |
| ZoomMed Inc | 154.28k | 1.46m | 2.16m | -- | -- | -- | 1.40 | 13.98 | 0.0107 | 0.0107 | 0.0011 | -0.0014 | 15.76 | -- | 46.89 | -- | 14,863.23 | -- | -- | -- | -- | -- | 943.16 | -- | -- | -- | -- | -- | 3,951.93 | -- | 114.30 | -- | -- | -- |
| EvokAI Creative Labs Inc | 0.00 | -13.65m | 2.28m | -- | -- | -- | -- | -- | -0.1467 | -0.1467 | 0.00 | -0.0105 | 0.00 | -- | 0.3277 | -- | -189.56 | -1,785.96 | -197.78 | -3,725.86 | -- | -- | -- | -- | -- | -137.12 | -- | -- | -- | -- | -3,520.74 | -- | -- | -- |
| Binovi Technologies Corp | -100.00bn | -100.00bn | 2.31m | 0.00 | -- | -- | -- | -- | -- | -- | -- | -0.0873 | -- | -- | -- | -- | -- | -170.25 | -- | -254.88 | -- | 71.98 | -- | -1,712.66 | 0.3215 | -- | -- | -- | -74.42 | 13.94 | -79.12 | -- | -- | -- |
| Lattice Biologics Ltd | 2.19m | -1.34m | 4.24m | -- | -- | -- | -- | 1.93 | -0.0105 | -0.0105 | 0.0172 | 0.0011 | 1.01 | 3.83 | 8.70 | -- | -61.69 | -- | -- | -- | 28.53 | -- | -61.08 | -- | 0.00 | -1.02 | 0.00 | -- | 12.60 | -- | -46.52 | -- | -- | -- |
| SQI Diagnostics Inc | 3.04m | -19.13m | 6.18m | 55.00 | -- | -- | -- | 2.03 | -0.0483 | -0.0483 | 0.0077 | -0.035 | 0.286 | 3.23 | 3.91 | -- | -179.74 | -147.99 | -- | -264.33 | 10.97 | 48.25 | -628.52 | -400.28 | 0.1193 | -3.03 | 24.07 | -- | 783.53 | 52.95 | -75.46 | -- | 42.57 | -- |
| Kovo+Holdings Inc | 15.17m | -7.66m | 7.99m | -- | -- | -- | -- | 0.5264 | -0.133 | -0.133 | 0.2636 | -0.0781 | 1.17 | -- | 48.85 | -- | -58.91 | -- | -242.80 | -- | -- | -- | -50.45 | -- | -- | -1.23 | 1.51 | -- | -5.04 | -- | -1,773.60 | -- | -- | -- |
| Evome Medical Technologies Inc | 57.98m | -19.39m | 8.37m | 195.00 | -- | -- | -- | 0.1444 | -0.2425 | -0.2425 | 0.6601 | -0.0279 | 1.07 | 3.21 | 6.91 | 297,326.20 | -35.78 | -- | -144.36 | -- | 34.58 | -- | -33.45 | -- | 0.2596 | -1.94 | 1.14 | -- | -- | -- | -- | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Cumberland Private Wealth Management, Inc.as of 09 Feb 2024 | 3.38m | 0.00% |
| Next Edge Capital Corp.as of 30 Jun 2024 | 0.00 | 0.00% |
